Coherus Oncology (CHRS) Minority Interest (2014 - 2018)
Coherus Oncology (CHRS) posted Minority Interest of -$1.3 million for Q2 2018, down 3.63% sequentially from -$1.3 million in Q1 2018, and down 4.52% YoY from -$1.4 million in Q2 2017.
Coherus Oncology (CHRS) Minority Interest (2014 - 2018) Analysis & Trends
Coherus Oncology has reported Minority Interest for 5 years, with the latest figure at -$1.3 million in Q2 2018.
- Quarterly Minority Interest fell 4.52% year-over-year to -$1.3 million in Q2 2018, while the trailing twelve-month figure through Jun 2018 was -$1.3 million (down 4.52% YoY) and the FY2017 annual result came in at -$1.3 million, down 9.89% from the prior year.
- Minority Interest retreated to -$1.3 million in Q2 2018 per CHRS's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Minority Interest peaked at -$44000.0 in Q4 2014 and troughed at -$1.3 million in Q2 2018.
- A 5-year average of -$872250.0 and a median of -$1.1 million in 2016 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2015 and 2018: Minority Interest tumbled 1540.91% in 2015, then dropped 4.52% in 2018.
- Over 5 years, Minority Interest stood at -$44000.0 in 2014, then plunged by 1540.91% to -$722000.0 in 2015, then tumbled by 62.47% to -$1.2 million in 2016, then decreased by 9.89% to -$1.3 million in 2017, then slipped by 4.03% to -$1.3 million in 2018.
- According to Business Quant data, Minority Interest over the past three periods registered -$1.3 million, -$1.3 million, and -$1.3 million for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Coherus Oncology | 203.82 Mn | 98.51 Mn | 10.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -1.34 Mn |
| Mar 31, 2018 | -1.29 Mn |
| Dec 31, 2017 | -1.29 Mn |
| Sep 30, 2017 | -1.29 Mn |
| Jun 30, 2017 | -1.28 Mn |
| Mar 31, 2017 | -1.22 Mn |
| Dec 31, 2016 | -1.17 Mn |
| Sep 30, 2016 | -1.15 Mn |
| Jun 30, 2016 | -1.06 Mn |
| Mar 31, 2016 | -872,000.00 |
| Dec 31, 2015 | -722,000.00 |
| Sep 30, 2015 | -533,000.00 |
| Jun 30, 2015 | -382,000.00 |
| Mar 31, 2015 | -158,000.00 |
| Dec 31, 2014 | -44,000.00 |
| Sep 30, 2014 | -155,000.00 |